Literature DB >> 7703309

CD4+ T lymphocyte depletion attenuates lipopolysaccharide-induced tumor necrosis factor secretion by alveolar macrophages in the mouse.

N B D'Souza1, F J Mandujano, S Nelson, W R Summer, J E Shellito.   

Abstract

Mechanisms underlying the control of cytokine secretion by alveolar macrophages are not fully understood. We hypothesized that T lymphocytes or their products modulate the capacity of alveolar macrophages to release cytokines in response to an exogenous stimulus. In this study, we investigated the role of lymphocytes expressing surface CD4 (CD4+) antigen in the regulation of tumor necrosis factor alpha (TNF-alpha) secretion by alveolar macrophages. Specific pathogen-free male BALB/c mice were injected intraperitoneally with 0.3 mg monoclonal anti-CD4 antibody or phosphate-buffered saline. Depletion of CD4+ splenic lymphocytes was confirmed 6 days later by flow cytometry. On day 6, mice were challenged intratracheally with E. coli lipopolysaccharide (LPS, 1-100 micrograms/100 g BW) or phosphate-buffered saline. The lungs were lavaged 3 h later and the bronchoalveolar lavage fluid assessed for TNF activity and cell recovery (total and differential). No TNF was detected in the lavage fluid of animals pretreated with antibody or phosphate-buffered saline and given phosphate-buffered saline intratracheally. However, the saline-treated mice challenged with LPS (100 micrograms/100 g BW) released 3.76 +/- 0.18 ng TNF/ml bronchoalveolar lavage fluid. In contrast, mice depleted of CD4+ T lymphocytes released almost 50% less TNF (1.94 +/- 0.23 ng TNF/ml lavage fluid, p < 0.001) in response to the same dose of LPS.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7703309

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  7 in total

1.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  T cell pathways involving CTLA4 contribute to a model of acute lung injury.

Authors:  Takeshi Nakajima; Carlos Jose Suarez; Ko-Wei Lin; Kai Yu Jen; Jan E Schnitzer; Samir S Makani; Nathan Parker; David L Perkins; Patricia W Finn
Journal:  J Immunol       Date:  2010-04-12       Impact factor: 5.422

3.  Dose-dependent activation of lymphocytes in endotoxin-induced airway inflammation.

Authors:  R Larsson; D Rocksén; B Lilliehöök; A Jonsson; A Bucht
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Acute alcohol intake impairs lung inflammation by changing pro- and anti-inflammatory mediator balance.

Authors:  Nympha B D'Souza El-Guindy; Willem J de Villiers; Dennis E Doherty
Journal:  Alcohol       Date:  2007-08       Impact factor: 2.405

5.  gammadelta T cells contribute to the systemic immunoglobulin E response and local B-cell reactivity in allergic eosinophilic airway inflammation.

Authors:  Linda Svensson; Bo Lilliehöök; Roland Larsson; Anders Bucht
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

6.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

7.  Rapamycin attenuates acute lung injury induced by LPS through inhibition of Th17 cell proliferation in mice.

Authors:  Zhao Yan; Zhang Xiaoyu; Song Zhixin; Qi Di; Deng Xinyu; Xia Jing; He Jing; Deng Wang; Zhong Xi; Zhang Chunrong; Wang Daoxin
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.